1. Home
  2. THAR vs DFLI Comparison

THAR vs DFLI Comparison

Compare THAR & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • DFLI
  • Stock Information
  • Founded
  • THAR 2017
  • DFLI 2020
  • Country
  • THAR United States
  • DFLI United States
  • Employees
  • THAR N/A
  • DFLI N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • DFLI Electronic Components
  • Sector
  • THAR Health Care
  • DFLI Technology
  • Exchange
  • THAR Nasdaq
  • DFLI Nasdaq
  • Market Cap
  • THAR 5.5M
  • DFLI 5.0M
  • IPO Year
  • THAR 2022
  • DFLI N/A
  • Fundamental
  • Price
  • THAR $1.46
  • DFLI $0.37
  • Analyst Decision
  • THAR Strong Buy
  • DFLI Strong Buy
  • Analyst Count
  • THAR 1
  • DFLI 1
  • Target Price
  • THAR $17.00
  • DFLI $1.50
  • AVG Volume (30 Days)
  • THAR 43.3K
  • DFLI 45.2M
  • Earning Date
  • THAR 08-08-2025
  • DFLI 08-13-2025
  • Dividend Yield
  • THAR N/A
  • DFLI N/A
  • EPS Growth
  • THAR N/A
  • DFLI N/A
  • EPS
  • THAR N/A
  • DFLI N/A
  • Revenue
  • THAR N/A
  • DFLI $51,496,000.00
  • Revenue This Year
  • THAR N/A
  • DFLI $30.09
  • Revenue Next Year
  • THAR N/A
  • DFLI $50.08
  • P/E Ratio
  • THAR N/A
  • DFLI N/A
  • Revenue Growth
  • THAR N/A
  • DFLI N/A
  • 52 Week Low
  • THAR $0.95
  • DFLI $0.15
  • 52 Week High
  • THAR $6.39
  • DFLI $8.37
  • Technical
  • Relative Strength Index (RSI)
  • THAR 39.40
  • DFLI 58.15
  • Support Level
  • THAR $1.60
  • DFLI $0.32
  • Resistance Level
  • THAR $1.75
  • DFLI $0.45
  • Average True Range (ATR)
  • THAR 0.10
  • DFLI 0.06
  • MACD
  • THAR -0.04
  • DFLI 0.03
  • Stochastic Oscillator
  • THAR 1.01
  • DFLI 42.33

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.

Share on Social Networks: